There were 1,435 press releases posted in the last 24 hours and 438,404 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image